Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Quarterly results
Acq. announced
Appointed director
|
|
TherapeuticsMD, Inc. (TXMD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/03/2023 |
8-K
| Resignation/termination of a director |
| 04/22/2020 |
8-K
| Resignation/termination of a director, Appointed a new director |
| 03/24/2020 |
8-K
| Quarterly results |
| 12/18/2013 |
8-K
| Resignation/termination of a director|
Docs:
|
"THERAPEUTICSMD NAMES RANDALL S. STANICKY TO BOARD OF DIRECTORS Boca Raton, FL - December 18, 2013 – TherapeuticsMD, Inc. , a women’ s healthcare company , announced today that Randall S. Stanicky, CFA, a highly-regarded senior equity analyst with extensive experience in the specialty pharmaceutical and healthcare services sectors, has been named to its Board of Directors, replacing Samuel A. Greco. Mr. Stanicky currently serves as Managing Director, Global Equity Research at RBC Capital Markets, focusing on the specialty pharmaceuticals sector and has spent almost 15 years in equity research covering healthcare stocks. He previously served in senior roles at Goldman Sachs and Canaccord Genuity on the sell side. His prior coverage experience within the healthcare sector has been broad, span..." |
|
|
|